Literature DB >> 10705090

Low incidence of H-, K- and N-ras oncogene mutations in cytological specimens of laryngeal tumours.

E Rizos1, G Sourvinos, D A Arvanitis, G Velegrakis, D A Spandidos.   

Abstract

Laryngeal cancer is a rare type of neoplasia, constituting approximately 2% of all human cancers. Mutations of the ras gene family is one of the main activating mechanisms in human cancer. Their involvement in head and neck cancer has been mainly demonstrated at the level of the overexpression whereas ras mutations in these cancers are rare in the Western world. In the present study we explored the incidence of codon 12-point mutation in the H-, K- and N-ras genes, in 41 laryngeal cytological specimens. These specimens corresponded to 19 benign and 22 malignant lesions of the larynx. Only two specimens carried a codon 12-point mutation in the K-ras gene (4.8%) while no mutation was detected in the H- and N-ras genes. K-ras mutations were detected in one benign and one malignant specimen. These results indicate low incidence of ras oncogene mutations in laryngeal cytological specimens.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10705090     DOI: 10.1016/s1368-8375(99)00032-9

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  6 in total

1.  Genomic dissection of the epidermal growth factor receptor (EGFR)/PI3K pathway reveals frequent deletion of the EGFR phosphatase PTPRS in head and neck cancers.

Authors:  Luc G T Morris; Barry S Taylor; Trever G Bivona; Yongxing Gong; Stephanie Eng; Cameron W Brennan; Andrew Kaufman; Edward R Kastenhuber; Victoria E Banuchi; Bhuvanesh Singh; Adriana Heguy; Agnes Viale; Ingo K Mellinghoff; Jason Huse; Ian Ganly; Timothy A Chan
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-07       Impact factor: 11.205

Review 2.  Anti-epidermal growth factor receptor therapy in head and neck squamous cell carcinoma: focus on potential molecular mechanisms of drug resistance.

Authors:  Carolien Boeckx; Marc Baay; An Wouters; Pol Specenier; Jan B Vermorken; Marc Peeters; Filip Lardon
Journal:  Oncologist       Date:  2013-07-02

3.  Impact of K-Ras Over-expression in Laryngeal Squamous Cell Carcinoma.

Authors:  Vasileios Papanikolaou; Aristeidis Chrysovergis; Stylianos Mastronikolis; Evangelos Tsiambas; Vasileios Ragos; Dimitrios Peschos; Despoina Spyropoulou; Pavlos Pantos; Athanasios Niotis; Nicholas Mastronikolis; Efthymios Kyrodimos
Journal:  In Vivo       Date:  2021 May-Jun       Impact factor: 2.155

4.  Mechanisms of acquired androgen independence during arsenic-induced malignant transformation of human prostate epithelial cells.

Authors:  Lamia Benbrahim-Tallaa; Mukta M Webber; Michael P Waalkes
Journal:  Environ Health Perspect       Date:  2006-11-20       Impact factor: 9.031

5.  Prevalence of K-RAS Codons 12 and 13 Mutations in Locally Advanced Head and Neck Squamous Cell Carcinoma and Impact on Clinical Outcomes.

Authors:  Eric Bissada; Olivier Abboud; Zahi Abou Chacra; Louis Guertin; Xiaoduan Weng; Phuc Félix Nguyen-Tan; Jean-Claude Tabet; Eve Thibaudeau; Louise Lambert; Marie-Lise Audet; Bernard Fortin; Denis Soulières
Journal:  Int J Otolaryngol       Date:  2013-04-30

6.  Prevalence of K-ras Codon 12 Mutations in Indian Patients with Head and Neck Cancer.

Authors:  Ashna Gauthaman; Anbalagan Moorthy
Journal:  Indian J Clin Biochem       Date:  2020-04-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.